Basic Search  |  Summaries  |  Advanced Search

Violation Tracker Individual Record

Company: SmithKline Beecham Corp.
Current Parent Company: GlaxoSmithKline
Parent at the Time of the Penalty Announcement:  subscribe to see this data field
Penalty: $10,000,000
Year: 2005
Date: April 13, 2005
Offense Group: competition-related offenses
Primary Offense: price-fixing or anti-competitive practices
Violation Description: SmithKline Beecham agreed to pay $10 million to settle multistate litigation alleging it obtained a patent on nabumetone through fraud on the United States Patent and Trademark Office and that it excluded generic competition for its product Relafen through sham patent litigation.
Level of Government: state
Action Type: agency action
Agency: Multistate Attorneys General Case
Civil or Criminal Case: civil
HQ Country of Current Parent: United Kingdom
Ownership Structure of Current Parent: publicly traded
Major Industry of Current Parent: pharmaceuticals
Specific Industry of Current Parent: pharmaceuticals
Source of Data: (click here)
Link to Archived Court Document:  subscribe to see this data field
Source Notes: If an online information source is not working, check the Violation Tracker Data Sources page for an updated link.
Current parent company note: Parent-subsidiary relationship is current as of the most recent revision listed in the Update Log.